Talquetamab
Janssen
['multiplemyeloma', 'talquetamab']
more than 70% of heavily pretreated patients taking #talquetamab for #multiplemyeloma see responses that deepen over time #ash22 
The American Journal of #ManagedCare is a peer-reviewed, indexed publication. https://t.co/I2WRhmhOVC offers news in health policy, disease states, and managed care.